Overview

Treatment of Strongyloides Infection

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the serologic response in patients with S. stercoralis infection after treatment with a regimen of two single doses of 200 µg/kg of ivermectin given 2 weeks apart versus a regimen of two single doses of 200 µg/kg of ivermectin given in two consecutive days.
Phase:
Phase 3
Details
Lead Sponsor:
Albert Einstein College of Medicine
Albert Einstein College of Medicine, Inc.
Treatments:
Ivermectin